Sign in
4

Changes in Ownership

Inhibitor Therapeutics, Inc. Filed Acc 0001144204-18-037560

Options or other derivatives

  • 10% owner bought 5,797,103 shares

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Mayne Pharma Ventures Pty Ltd 10% owner 2018-07-05 Purchase · Series B Convertible Preferred Stock +2,318,841 5,797,102 D
Mayne Pharma Ventures Pty Ltd 10% owner 2018-07-05 Purchase · Series A Warrants to Purchase Common Stock +1,739,131 1,739,131 D
Mayne Pharma Ventures Pty Ltd 10% owner 2018-07-05 Purchase · Series B Warrants to Purchase Common Stock +1,739,131 1,739,131 D
Loading xslF345X03/tv498045_4.xml…